NEFL and Alzheimer disease: The plasma NfL/p‐tau217 ratio was reduced in AD compared to bvFTD (β = −1.57 [−2.16, −0.94], p < 0.001) and PPD (β = −0.99 [−0.58, −1.34], p < 0.001).